Atlas Trials

Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects

Clinical trial NCT02061358 · COMPLETED

Trial details

NCT number
NCT02061358
Sponsor
Emergent BioSolutions
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Viral Infection
Start date
2014-07-01
Primary completion
2015-07-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.